ProPhase Labs, Inc.
PRPHOTCCIK 868278HealthcareFiscal year ends Dec 31
Reports and events: 400 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1920:31 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-039224 |
| 2026-08-0621:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-26-036383 |
| 2026-07-0919:12 ET | 10-Q/A | Quarterly report, amendedPeriod 2026-03-31 | 0001493152-26-032658 |
| 2026-07-0713:23 ET | 10-Q/A | Quarterly report, amendedPeriod 2026-03-31 | 0001493152-26-032269 |
| 2026-06-3020:50 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-031301 |
| 2026-06-0121:13 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000868278-26-000005 |
| 2026-02-1322:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-006784 |
| 2026-02-1322:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-006785 |
| 2026-01-2716:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-003724 |
| 2026-01-2322:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-003460 |
| 2026-01-2322:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-003456 |
| 2026-01-0922:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-001143 |
| 2026-01-0922:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-001134 |
| 2026-01-0222:10 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-26-000175 |
| 2025-12-1920:37 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-028537 |
| 2025-12-1918:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-028483 |
| 2025-12-1818:30 ET | 8-K/A | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-028317 |
| 2025-12-1216:41 ET | 8-K/A | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-027399 |
| 2025-12-1223:07 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-027317 |
| 2025-11-2619:15 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-025102 |
| 2025-11-2521:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-024986 |
| 2025-11-2521:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-024988 |
| 2025-11-1921:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000868278-25-000017 |
| 2025-11-1914:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-024174 |
| 2025-10-3121:38 ET | DEF 14A | Proxy statementPeriod 2025-10-31 | 0001493152-25-020375 |
| 2025-10-2121:29 ET | S-1 | Registration statement | 0001493152-25-018819 |
| 2025-10-1518:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-018123 |
| 2025-09-1820:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-014057 |
| 2025-09-1513:16 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-013415 |
| 2025-08-2810:15 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-012414 |
| 2025-08-1912:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-024730 |
| 2025-08-1521:08 ET | DEF 14A | Proxy statementPeriod 2025-08-15 | 0001641172-25-024375 |
| 2025-08-1321:07 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000868278-25-000011 |
| 2025-08-1313:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-023344 |
| 2025-08-0620:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001641172-25-022426 |
| 2025-07-2912:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-021262 |
| 2025-07-2812:20 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-021109 |
| 2025-07-2523:15 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001641172-25-020898 |
| 2025-07-2312:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-020651 |
| 2025-07-2112:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-020357 |
| 2025-07-0113:00 ET | 8-K | 3.01 Delisting notice | 0001641172-25-017286 |
| 2025-06-2713:00 ET | 8-K/A | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-016815 |
| 2025-06-2621:25 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-016710 |
| 2025-06-2621:14 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-016692 |
| 2025-06-2521:07 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001641172-25-016501 |
| 2025-06-2313:00 ET | DEF 14A | Proxy statementPeriod 2025-06-23 | 0001641172-25-016010 |
| 2025-05-2020:06 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000868278-25-000007 |
| 2025-05-2012:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-011607 |
| 2025-04-3021:23 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001641172-25-007899 |
| 2025-04-0121:33 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000868278-25-000003 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.